Affy Grants Premier Status to Beckman Coulter's ArrayPlex Target Prep Tool | GenomeWeb
NEW YORK (GenomeWeb News) — Beckman Coulter today said it will market its Biomek 3000 ArrayPlex for target RNA preparation to Affymetrix customers after it received Premier Application Status from the chip vendor.
Beckman Coulter said the ArrayPlex is an alternative for Affy customers who are looking for a smaller, less-expensive option for medium- to low-throughput applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.